INCLUSION AND CHARACTERIZATION OF KETOPROFEN INTO DIFFERENT MESOPOROUS SILICA NANOPARTICLES USING THREE LOADING METHODS
Objective: The objective of the present study was to encapsulate ketoprofen into MCM-41, SBA-15 and uncalcined SBA-15 (unc SBA-15) using different loading methods. Investigate the effect of using different loading methods, and the effect of pore sizes on the loading capacity of mesoporous silica. Finally, determine if any changes in the mesoporous structure occurred after KP loading.
Methods: Ketoprofen (KP) with about 1.5 nm molecular size was selected for encapsulation into three mesoporous silica nanoparticles (MSN). These MSN particles were selected to cover a wide range of pore diameters: MCM-41 (3.4 nm), SBA-15 (6.2 nm) and uncalcined SBA-15 (7.0 nm). Loading of KP was done by three loading methods namely rotavapor, soaking, and immersion method. The loading capacity was examined via solvent extraction. Characterization of the loaded mesoporous silica nanoparticles was done by high resolution transmission electron microscopy (HRTEM), small angle X-ray diffraction (SAXRD), nitrogen adsorption/desorption isotherms, differential scanning calorimetry (DSC), and Fourier transform infrared (FT-IR) spectroscopy.
Results: KP was successfully encapsulated into MCM-41, SBA-15 and uncalcined SBA-15 without affecting the mesoporous structure. The loading process was done using three different loading methods. Rotavapor loading method yielded higher loading capacities compared to soaking and immersion method. Another important factor that affected the amount of loaded KP into MSN particles were the Pore sizes of the host particles. MCM-41, which had the smallest pore size, had the least amount of loaded drug. On the other hand, uncalcined SBA-15, which had the largest pore size, had the highest amount of loaded KP.
Conclusion: This study is a promising issue for the incorporation of KP into different mesoporous silica nanoparticles.
2. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME, Kresge CT, Schmitt KD, et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J of the American Chemical Society 1992;114:10834-43.
3. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992;359:710-2.
4. Zhai Q-Z. Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug. J of Microencapsulation 2013;30:173-80.
5. 5. Slowing, II, Vivero-Escoto JL, Wu CW, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Advanced Drug Delivery Rev 2008;60:1278-88.
6. Ambrogi V, Perioli L, Marmottini F, Giovagnoli S, Esposito M, Rossi C. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. European journal of pharmaceutical sciences: official J of the Eur Federation for Pharm Sci 2007;32:216-22.
7. Vallet-Regi M, RÃ¡mila A, Del Real RP, PÃ©rez-Pariente J. A New Property of MCM-41:â€‰ Drug Delivery System. Chemistry of Materials 2001;13:308-11.
8. Zhao D, Feng J, Huo Q, Melosh N, Fredrickson GH, Chmelka BF, et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Sci 1998;279:548-52.
9. Kantor TG. Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy 1986;6:93-103.
10. Al-Kady AS, Gaber M, Hussein MM, Ebeid el ZM. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect. Eur Jof Pharmaceutics and Biopharmaceutics: official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 2011;77:66-74.
11. Fagerlund G. Determination of specific surface by the BET method. Mat Constr 1973;6:239-45.
12. De Boer JH, Lippens BC, Linsen BG, Broekhoff JCP, van den Heuvel A, Osinga TJ. Thet-curve of multimolecular N2-adsorption. J of Colloid and Interface Sci 1966;21:405-14.
13. Barrett E, Joyner L, Halenda P. The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms. J Am Chem Soc 1951;73:373-80.
14. Patil A, Chirmade UN, Slipper I, Lamprou DA, Urquhart A. Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide. J of Nanomedicine and Nanotechnology 2011;02:1-8.
15. Souza MJB, Araujo AS, Pedrosa AMG, Marinkovic BA, Jardim PM, Morgado Jr E. Textural features of highly ordered Al-MCM-41 molecular sieve studied by X-ray diffraction, nitrogen adsorption and transmission electron microscopy. Materials Letters 2006;60:2682-5.
16. Wu S, Han Y, Zou Y-C, Song J-W, Zhao L, Di Y, et al. Synthesis of Heteroatom Substituted SBA-15 by the â€œpH-Adjustingâ€ Method. Chemistry of Materials 2004;16:486-92.
17. Li Y, Zhang W, Zhang L, Yang Q, Wei Z, Feng Z, et al. Direct Synthesis of Alâˆ’SBA-15 Mesoporous Materials via Hydrolysis-Controlled Approach. The J of Physical Chemistry B 2004;108:9739-44.
18. Kang F, Wang Q, Xiang S. Synthesis of mesoporous Al-MCM-41 materials using metakaolin as aluminum source. Materials Letters 2005;59:1426-9.
19. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D, et al. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous and Mesoporous Materials 2006;92:1-9.
20. Gregg SJ, Sing KSW. Adsorption, surface area, and porosity. 2nd ed. London: Academic Press; 1991.
21. Branton PJ, Hall PG, Sing KSW. Physisorption of nitrogen and oxygen by MCM-41, a model mesoporous adsorbent. J of the Chemical Society, Chemical Communications 1993;0:1257-8.
22. Branton PJ, Hall PG, Sing KSW, Reichert H, Schuth F, Unger KK. Physisorption of argon, nitrogen and oxygen by MCM-41, a model mesoporous adsorbent. J of the Chemical Society, Faraday Transactions 1994;90:2965-7.
23. Schulz-Ekloff G, Rathousky J, Zukal A. Controlling of morphology and characterization of pore structure of ordered mesoporous silicas. Microporous and Mesoporous Materials 1999;27:273-85.
24. Lowell S, Shields JE, Thomas MA, Thommes M. Characterization of Porous Solids and Powders: Surface Area, Pore Size and Density. 4th ed. Dordrecht: Springer Netherlands; 2006.
25. Szegedi A, Popova M, Goshev I, MihÃ¡ly J. Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release. J of Solid State Chemistry 2011;184:1201-7.
26. Wu S, Song K, Guan J, Kan Q. Synthesis and characterization of super-microporous material with enhanced hydrothermal stability. Bull Mater Sci 2011;34:979-83.
27. Li XD, Zhai QZ. Characterization of methylated nanoscale MCM-41 material. JICS 2011;8:S1-S8.
28. Azimov F, Markova I, Stefanova V, Sharipov K. Synthesis and characterization of SBA-15 and Ti-SBA-15 nanoporous materials for DME catalysts. J of the University of Chemical Technology and Metallurgy 2012;47:333-40.
29. Tian B, Liu X, Yu C, Gao F, Luo Q, Xie S, et al. Microwave assisted template removal of siliceous porous materials. Chemical Communications 2002;0:1186-7.
30. Cauda V, MÃ¼hlstein L, Onida B, Bein T. Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica. Microporous and Mesoporous Materials 2009;118:435-42.
31. Cauda V, Onida B, Platschek B, MÃ¼hlstein L, Bein T. Large antibiotic molecule diffusion in confined mesoporous silica with controlled morphology. J of Materials Chemistry 2008;18:5888.
32. Yue MB, Chun Y, Cao Y, Dong X, Zhu JH. CO2 Capture by As-Prepared SBA-15 with an Occluded Organic Template. Advanced Functional Materials 2006;16:1717-22.
33. Liversidge GG. Ketoprofen In: Analytical Profiles of Drug Substances Volume 10. In: Florey K, editor. London: Academic Press; 1981. p. 443-71.
34. TiÅ£a D, FuliaÅŸ A, TiÅ£a B. Thermal stability of ketoprofenâ€”active substance and tablets. J Therm Anal Calorim 2011;105:501-8.